drugset / Trial / NCT01984931

Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting

NCT01984931

RandomizedParallel-groupDouble-blindPrevention

Summary

This study will determine if giving Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)orally will be effective as a prophylactic anti-emetic drug for patients who underwent arthroscopic rotator cuff repair under general anesthesia.

Timeline

Start
2013-10
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 8.46 mg Intravenous
Subject Trimebutine Small molecule 300 mg Oral

Indications

No indication recorded.